Home＞BUSINESS
Sanofi, Asahi Kasei Pharma Tie Up for Anti RA Treatment Kevzara(Dec.11.2017)
Sanofi and Asahi Kasei Pharma said on December 8 that they have entered into a license agreement for the marketing of Sanofi’s rheumatoid arthritis (RA) treatment Kevzara subcutaneous injection (sarilumab) in Japan ...
(LOG IN FOR FULL STORY)
-
-
Lilly Japan Marks Opening of New Kobe Headquarters
Jul.17
- Taiho Exercises Option to Gain Asian Rights to Arcus’ I/O Candidate Jul.17
- Takeda Jettisons Japan Rights to Obesity Drug OBLEAN after Long Listing Limbo Jul.17
- As Biosimilars Show Mixed Performances, Lantus Follow-On Is on a Roll Jul.13
- Ninlaro Hits Primary Endpoint in Post-Transplant Multiple Myeloma: Takeda Jul.13
- Lilly Japan Marks Opening of New Kobe Headquarters(Jul.17)
- Boehringer’s DPP-4/SGLT2 Combo Up for MHLW Panel Review on July 27(Jul.17)
- Taiho Exercises Option to Gain Asian Rights to Arcus’ I/O Candidate(Jul.17)
- Takeda Jettisons Japan Rights to Obesity Drug OBLEAN after Long Listing Limbo(Jul.17)
- MHLW to Introduce Guidelines for Sales Reps’ Activities, Calling for the Creation of Supervising Offices(Jul.17)
